Sbi Securities Co., Ltd. Immuneering Corp Transaction History
Sbi Securities Co., Ltd.
- $3.48 Trillion
- Q2 2025
A detailed history of Sbi Securities Co., Ltd. transactions in Immuneering Corp stock. As of the latest transaction made, Sbi Securities Co., Ltd. holds 74 shares of IMRX stock, worth $240. This represents 0.0% of its overall portfolio holdings.
Number of Shares
74
Previous 74
-0.0%
Holding current value
$240
Previous $112,000
122.32%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding IMRX
# of Institutions
38Shares Held
4.84MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA1.06MShares$3.43 Million0.0% of portfolio
-
Marshall Wace, LLP London, X0808KShares$2.63 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD659KShares$2.14 Million0.0% of portfolio
-
Black Rock Inc. New York, NY533KShares$1.73 Million0.0% of portfolio
-
Morgan Stanley New York, NY467KShares$1.52 Million0.0% of portfolio
About Immuneering Corp
- Ticker IMRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,392,300
- Market Cap $85.8M
- Description
- Immuneering Corporation, a biopharmaceutical company, focuses on the oncology and neuroscience product candidates. Its lead product candidates include IMM-1-104, a dual-MEK inhibitor to treat patients with cancer, including pancreatic, melanoma, colorectal, and non-small cell lung cancer caused by mutations of RAS and/or RAF; and IMM-6-415 to tr...